Hims & Hers settles with Novo Nordisk, removing litigation risk and adding branded GLP-1s to platform
The settlement eliminates FDA and litigation overhang, adds FDA-approved Ozempic/Wegovy at competitive self-pay prices, and positions HIMS as a distribution platform for future ob…